Matthew S. Schwartz
Matthew S. Schwartz is a reporter with NPR's news desk. Before coming to NPR, Schwartz worked as a reporter for Washington, DC, member station WAMU, where he won the national Edward R. Murrow award for feature reporting in large market radio. Previously, Schwartz worked as a technology reporter covering the intricacies of Internet regulation. In a past life, Schwartz was a Washington telecom lawyer. He got his J.D. from Georgetown University Law Center, and his B.A. from the University of Michigan ("Go Blue!").
-
"Knucksie," as he was known, pitched the most games of any Braves pitcher. He retired at 48 years old in 1987. -
Authorities revealed that DNA testing shows the man believed to be the perpetrator of the Christmas Day incident died in the blast. -
A day after the early Christmas explosion injured three people and damaged dozens of buildings in downtown Nashville, Tenn., large swaths of the state's communications networks were still down. -
"Vaccines for all, especially for the most vulnerable and needy of all regions of the planet," Pope Francis said at the Vatican on a subdued Christmas Day. -
All of London and much of southeastern England is now under strict "Tier 4" lockdown restrictions after the discovery of what appears to be a new, more transmissible variant of the coronavirus. -
The official moniker, announced by Vice President Pence at a White House ceremony, comes one year after the creation of the newest military branch. The name drew raised eyebrows online. -
The two sides have been trying to hammer out the details of a post-Brexit world for most of the year. Talks will continue ahead of a fast-approaching deadline, leaders announced on Sunday. -
The media mogul and prominent critic of China's ruling Communist Party remains in prison after his arrest on accusations he violated a controversial new national security law. -
President Trump said on Twitter that his personal attorney, Rudy Giuliani, had tested positive for the coronavirus. -
The U.K. was the first Western country to approve Pfizer's coronavirus vaccine for emergency use. In the U.S., the Food and Drug Administration could vote to approve the vaccine as early as Thursday.
